shutterstock_1542671348_rafael_trafaniuc-1
Rafael Trafaniuc / Shutterstock.com
5 January 2023FeaturesGeneticsBrian Hausman

Will de-extinct animals be patent eligible in the US?

Using DNA from extinct animals in conjunction with advanced technology to bring these animals back to life has been popularised by science fiction films such as “Jurassic Park”. However, developments in “de-extinction” processes have made the possibility of resurrecting these extinct animals a reality.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
1 March 2022   Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.
Biotechnology
11 July 2017   The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process.

More on this story

Americas
1 March 2022   Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.
Biotechnology
11 July 2017   The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process.

More on this story

Americas
1 March 2022   Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.
Biotechnology
11 July 2017   The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process.